SCHEMBL5377724

SCHEMBL5377724

Cc1nc(N(C)C)cn1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.41
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 3/20 0.38
KDM4E B2RXH2 3/20 0.38
CYP1A2 P05177 3/20 0.38
HPGD P15428 1/20 0.38
BLM P54132 1/20 0.38
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
USP2 O75604 2/20 0.37
ALOX15 P16050 2/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
NCF1 P14598 1/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5374967 0.82 GABRA2 (0.48) ALDH1A1HSD17B10KDM4EHPGDHTT
SCHEMBL12247671 0.76 GRM5 (0.49) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL11856799 0.73 GRM5 (0.43) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL27997348 0.73 GRM5 (0.43) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL2378788 0.73 GRM5 (0.43) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL5366242 0.73 DDB1 (0.44) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL14007394 0.72 SMN1; SMN2 (0.48) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL5374700 0.70 GRM5 (0.41) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL21668017 0.70 GRM5 (0.41) GRM5DDB1CRBNALDH1A1HSD17B10
SCHEMBL21314950 0.69 NOTUM (0.50) GRM5DDB1CRBNALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US claimed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US claimed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP claimed
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US disclosed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US disclosed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers KRT18, VIM, NDUFS6 GRM5 3386/4885DDB1 1390/4885CRBN 1586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.